Latest / Public Health Review Morning Edition / 1057: STI Trends: Progress, Prevention, and the Urgent Rise in Congenital Syphilis
Transcript
- 0:02This is Public Health Review Morning Edition for Monday,
- 0:04January 26th, 2026. I'm John Chan with news from the
- 0:08Association of State and Territorial Health Officials.
- 0:11Today we discussed new CDC surveillance data that shows
- 0:15encouraging declines in several sexually transmitted infections,
- 0:19though a troubling increase in syphilis among newborns.
- 0:23As we continue our legislative prospectus series examining the
- 0:26public health policy trends set to shape 2026, our guest is the
- 0:30Director of the Division of STD Prevention at the National
- 0:34Center for HIV, Viral Hepatitis, STD and TB Prevention.
- 0:39Doctor Bradley Stoner. Doctor Bradley.
- 0:41Stoner welcome. To the show.
- 0:42Thank you very much. Glad to be here.
- 0:44Doctor Stoner What are the big takeaways from the 2024 STI
- 0:49surveillance data? Well, the report shows that last
- 0:51year in 2024, syphilis and newborns increased for the 12th
- 0:55year in a row in the United States, with nearly 4000 cases
- 0:59of newborn syphilis reported to the CDC.
- 1:02Now, this was a 2% increase relative to the previous year
- 1:06compared to double digit increases in some recent years.
- 1:09So there is evidence of a slowing of this increase, but
- 1:12still 2024 cases were nearly 700% higher than 10 years ago.
- 1:17So there's a long way to go to address this deadly but
- 1:19preventable consequence of the ongoing syphilis epidemic.
- 1:22Now, the report also shows that overall, the STI burden remains
- 1:26substantial in the United States, but there are signs of
- 1:29progress that hopefully will continue.
- 1:31The latest data show that more than 2.2 million STI's were
- 1:35reported in 2024, and this is a 9% decline from 2023.
- 1:40Moreover, primary and secondary syphilis cases, which are the
- 1:43most infectious stages of syphilis, declined by nearly
- 1:4622%. And this is the second year in a
- 1:49row of primary and secondary syphilis declines.
- 1:51Chlamydia cases declined by 8% also for second year in a row,
- 1:56and gonorrhea cases declined by nearly 10%.
- 1:59And this is the third year in a row we've seen gonorrhea
- 2:01declines. So there is room for optimism,
- 2:05but we cannot take our eye off the goal, which is slowing and
- 2:09reversing the STI epidemic completely.
- 2:12Yeah, that. Sounds there's a There's a mixed
- 2:15bag there. How do you how do you parse
- 2:17this? Well, we clearly think that the
- 2:19national declines are tangible evidence of the important impact
- 2:22of public health efforts. I consider this the prevention
- 2:25impact, the value of prevention and the efforts that we're doing
- 2:29at the CDC and national level to provide leadership for state and
- 2:33local health departments which are doing the work on the
- 2:35ground. This includes, first of all,
- 2:37work to increase awareness of the SDI epidemic at the state
- 2:41and local level. So publicizing St.
- 2:44IS as a public health problem and creating prioritization of
- 2:47the need for STI prevention and helping state and local health
- 2:50departments prioritize St. IS through awareness.
- 2:54We also are working to expand public health efforts to control
- 2:57St. IS, which includes increased
- 2:59partner outreach and notification efforts, increased
- 3:02awareness of clinical service availability and expanded use of
- 3:06what we call expedited partner therapy, which is the provision
- 3:09of treatment to patients to provide to their partners
- 3:13without the need for a clinical exam for those partners.
- 3:15So all of these things are tools that we have to promote STI
- 3:19prevention. And finally, I would point out
- 3:21that we're expanding efforts to increase uptake of prevention
- 3:26innovations like self tests for STI's, an increased use of doxy
- 3:32PEP, which is the provision of doxycycline as post exposure
- 3:35prophylaxis to patients with an STI to reinfection.
- 3:40So all of these are really excellent approaches to STI's,
- 3:43but we really have to accelerate our progress to stop the STI
- 3:47epidemic. So although we're encouraged by
- 3:50the the data in the in the report, in some cases, we really
- 3:53our goal is to is to capitalize on these results and to ensure
- 3:59that the SDI epidemic comes under control.
- 4:01Yeah, as you said, evidence is slowing, but rates are still
- 4:05going up. Yes.
- 4:06And I don't want to lose track of the 4000, nearly 4000 cases
- 4:09of congenital syphilis because this is a a major problem for us
- 4:14and something that we can do something about.
- 4:16Is there a context within demographic breakdowns?
- 4:19I mean, how, How else should we think about this?
- 4:22Well, it's important to remember that the 2024 surveillance
- 4:26report is provisional, which means that the data have not
- 4:29been finalized. And so we just don't have the
- 4:32data to say where in the country population level specific
- 4:36differences are occurring. We know that considering the
- 4:39surveillance data specifically, there are the nearly 4000 cases
- 4:42of newborn syphilis, which I talked about previously, which
- 4:45were reported to CDC in 2024. And that beyond the surveillance
- 4:48data, we know that CD, that CDC estimates one in five people in
- 4:52the United States has an STI. And so the STI's affect the
- 4:55health of millions of Americans. And while the STI epidemic
- 4:59touches nearly every community, some geographic areas and
- 5:02populations may experience increases or decreases not
- 5:05reflected by the newest 2024 national data.
- 5:07So we just can't make those determinations yet.
- 5:10What's happening is that CDC is migrating.
- 5:12It's a national Notifiable Diseases Surveillance System, or
- 5:16NNDSS data, and it's processing to a new platform called One CDC
- 5:21Data Platform or One CDP. And because of this, CDC has
- 5:25postponed reconciliation and publication of 2024 case
- 5:29surveillance data to allow state and local health departments and
- 5:31CDC more time to onboard the one CDP.
- 5:34So the final numbers may change for 2024, but the overall trends
- 5:39are there and we just can't make population level specific
- 5:42analysis at this time. We just don't have those data.
- 5:44But we feel it's important to release STI data in a timely way
- 5:48so that the 2024 provisional report is essential because CDC
- 5:53and local and state STI programs rely on these data to inform
- 5:56their ongoing STI pension efforts.
- 6:00Sure, absolutely. So with that in mind, how should
- 6:04local agencies start thinking about how they should use these
- 6:07results to sort of drive their interventions?
- 6:09It sounds like working towards lowering infant syphilis is a
- 6:13big one. Lowering infant syphilis is a
- 6:15big one, and we feel that the importance of having and sharing
- 6:18updated data at the local level for communities is critical, and
- 6:22CDC is committed to making this easier.
- 6:24For example, health departments can access county level syphilis
- 6:27data from our website to identify counties with high
- 6:30rates of syphilis, and these data can then be used to help
- 6:32notify physicians in these counties to encourage more
- 6:35testing and coordinated treatment.
- 6:37So this is important not just for overall syphilis, but for
- 6:40maternal syphilis. So identifying pregnant women
- 6:43with syphilis and providing treatment to prevent syphilis
- 6:45and newborns. Now I would say, John, that
- 6:48while the data indicate we may be turning the corner in some
- 6:51respects, we must accelerate the progress to stop the STI
- 6:54epidemic and its most tragic consequences.
- 6:56We have excellent resources at CDC, such as our updated program
- 7:01guidance for STI programs. We call these the program
- 7:03Operation Considerations for STI Prevention and also an updated
- 7:08outbreak tool kit known as the STI Outbreak Preparedness and
- 7:11Response Toolkit. These are valuable resources to
- 7:14assist state, tribal, local, and territorial health departments
- 7:17in preparing for and responding to sexually transmitted
- 7:20infection outbreaks. And what can?
- 7:24States. Sort of take away from the
- 7:26results in terms of again either prioritizations or just sort of
- 7:32lessons learned from what's been working, what hasn't been
- 7:34working. Well, CDC is empowering States
- 7:37and communities to prioritize STI control so that we can
- 7:40address the epidemic at federal, state, and local levels.
- 7:44There are several areas that can be prioritized to strengthen
- 7:47response to STI efforts and jurisdictions, including, for
- 7:50example, enhanced screening and treatment of pregnant women for
- 7:53syphilis and identifying maternal syphilis cases and
- 7:56providing treatment before the case is advanced.
- 7:59This is probably one of the most important ways that we can work
- 8:01with state and local partners to prevent congenital syphilis.
- 8:05We're also very excited about expanded use of Doxy PEP for
- 8:08doxycycline as post exposure prophylaxis in STI clinics and
- 8:12HIV care and prevention clinics and this will help prevent
- 8:15recurrence of chlamydia as well as syphilis in persons who are
- 8:18diagnosed with these infections. I want to point out that we are
- 8:22paying very close attention to antimicrobial resistance and
- 8:25gonorrhea. So heightened awareness and
- 8:27response to antimicrobial resistance for gonorrhea if and
- 8:31when it does occur in the US is part of the CDC focus.
- 8:35We have a whole program which we call cargoes combating
- 8:38antimicrobial resistant gonorrhea and other STIs, which
- 8:41tracks gonorrhea resistance nationally.
- 8:44So we're paying very close attention to that.
- 8:46CDC is promoting expanded use of new testing technologies such as
- 8:51self tests for syphilis that can I get identify new cases in non
- 8:55clinical settings. And state and territorial health
- 8:57departments can provide avenues for community based
- 9:00organizations and other groups to access point of care tests
- 9:03for syphilis. And one test is now over the
- 9:06counter as well as point of care tests for gonorrhea and
- 9:09chlamydia. And finally, I would say
- 9:11reaching people more effectively by offering STI testing and
- 9:14treatment in more settings where people access care and services.
- 9:18Doctor Stoner, I'm wondering, you mentioned the CDC is
- 9:21migrating its data to a new platform.
- 9:24Do you have a sense of the road map to completion and what the
- 9:28new platform can offer public health?
- 9:31Officials. Well, the new platform is called
- 9:34One CDC data Platform. And my understanding is that the
- 9:37migration to this new platform will occur in 2026.
- 9:40When that happens, we will be able to finalize 2024 and 2025
- 9:44surveillance data. There's a bit of a delay, but it
- 9:48will also allow greater access to data across a variety of
- 9:52reportable conditions. So the expectation is that the
- 9:55new platform will be more nimble and more accessible to partners.
- 10:00So, so while this allows us at this point, we're required to
- 10:04issue provisional data on St. is we'll have a final STI
- 10:08surveillance report for 2024 and 2025 available in the coming
- 10:13year. Yeah, more robust look, even
- 10:16though right now data is somewhat rough at best.
- 10:20I think we don't think that the overall trends will change, but
- 10:23the some of the specifics may we, we have enough data to know
- 10:27that the overall case burden will remain about the same, but
- 10:31some of the specifics at the local level may change in terms
- 10:35of case numbers. Doctor Bradley Stoner is the
- 10:40Director of the Division of STD Prevention at the National
- 10:43Center for HIV, Viral Hepatitis, STD, and TB Prevention.
- 10:48He joined us as part of our legislative prospectus series
- 10:51examining the policy trends set to shape public health in 2026.
- 10:57Access to contraception is changing and pharmacies are at
- 11:01the center of it. With the FDA's approval of the
- 11:03first over the counter birth control pill, more people can
- 11:06now get contraception without a doctor's visit, especially those
- 11:10who are uninsured, live in rural areas, or previously relied on
- 11:14less effective methods. Early research shows OTC access
- 11:18is already closing gaps in care by making contraception more
- 11:21convenient and flexible. But this promise comes at a time
- 11:25when pharmacies themselves are under strain, facing closures,
- 11:29workforce shortages and even insurance coverage that can
- 11:32drive up out of pocket costs. Public health agencies have a
- 11:35critical role to play improving reimbursement, supporting
- 11:39pharmacy capacity, expanding retail and alternative
- 11:42distribution models, and educating both consumers and
- 11:45providers. Learn more at the link in the
- 11:48show notes. Astos Organizational Strategic
- 11:53Planning Guide provides health agencies with an overview of the
- 11:56organizational strategic planning process comprised of
- 12:00seven major phases that an organization should complete on
- 12:03a recurring basis to adapt and refine their plans over time.
- 12:07This allows organizations to remain responsible as their
- 12:10needs and goals evolve. In addition, the guide reviews
- 12:13keys to success and highlights tips for addressing common
- 12:16challenges for each phase. It helps organizations better
- 12:20navigate uncertainties, anticipate challenges and
- 12:22achieve success in their strategic planning.
- 12:25Find a link in the show notes. This has been Public Health
- 12:28review Morning edition. I'm John Sheehan for the
- 12:31Association of State and Territorial Health Officials.